Conduit Pharmaceuticals Inc. (NASDAQ: CDT) Stock Information | RedChip

Conduit Pharmaceuticals Inc. (NASDAQ: CDT)


$0.0569
+0.0024 ( +5.18% ) 4.0M

Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Market Data


Open


$0.0569

Previous close


$0.0545

Volume


4.0M

Market cap


$6.76M

Day range


$0.0533 - $0.0581

52 week range


$0.0510 - $5.4399

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 May 15, 2024
10-q Quarterly Reports 71 May 14, 2024
4 Insider transactions 1 Apr 24, 2024
4 Insider transactions 1 Apr 24, 2024
4 Insider transactions 1 Apr 24, 2024
10-k Annual reports 90 Apr 16, 2024
8-k 8K-related 16 Apr 16, 2024
nt Quarterly Reports 1 Apr 01, 2024
4 Insider transactions 1 Dec 14, 2023
4 Insider transactions 1 Dec 05, 2023

Latest News